As many as 60 million people, that’s 20 % of Americans, deal with it irritable bowel syndrome (IBS).
IBS is a chronic condition that affects the lower gastrointestinal tract. It also causes the colon to be irritable and spastic, which causes the abdominal discomfort associated with changes in the consistency and/or frequency of bowel movements.
The causes of IBS are not yet fully known, but are believed to be a result of a combination of factors, including bacterial imbalance, food allergies and parasites.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
